Kiora Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Kiora Pharmaceuticals

10/05/2024 14:11

* Kiora Pharmaceuticals Inc  KPRX.OQ  reported quarterly
adjusted
earnings of 38 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of $-1.00.  The lone analyst forecast for the
quarter was for a loss of 7 cents per share. 
    * Revenue was $16.00 million​; analysts expected zero. 
    * Kiora Pharmaceuticals Inc shares had fallen by 31.3% this
quarter and lost 7.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 35.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Kiora
Pharmaceuticals Inc is $3.00 

This summary was machine generated from LSEG data May 10 at
01:10 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.07          0.38           Beat
 Dec. 31 2023      -0.42          -0.47          Missed
 Sep. 30 2023      -0.35          -0.89          Missed
 Jun. 30 2023      -1.07          -0.79          Beat